Take a look at our infographic – we explore our current knowledge of the interactions between alcohol and epigenetic mechanisms, and take a look at the latest research and drug targets.
In this interview, Patricia Garcez discusses her work on Zika virus and its disruption of normal cell division and differentiation, and her hopes for the field in the coming months and years.
Is bone marrow transplantation a viable treatment option for relapsing–remitting MS? Jeffrey Cohen discusses pros and cons of the technique.
In this interview, Mark Frasier discusses a recent Editorial from the Michael J. Fox Foundation and looks ahead to the future of precision medicine for Parkinson’s disease.
We spoke to Erica McGrath, University of Texas Medical Branch in Galveston (TX, USA), who presented her work on susceptibility to Zika virus at SfN 2016.
In this podcast we discuss the current outlook on ADHD and its diagnosis and treatment, as well as debates in the field and how the condition continues to shift in perception and treatment.
In this interview, Michael Turner (ICHIRF) discusses the Concussion in Sport project, as well as the current issues facing the field and his expectations for the upcoming Berlin meeting.
Reid Alisch discusses the role of epigenetics in neuropsychiatric disorders, and how new epigenetic research could change future research and treatment practices.